According to TipRanks.com, Tewari is a 5-star analyst with an average return of 30.3% and a 66.7% success rate. Tewari covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Madrigal Pharmaceuticals, and BioMarin Pharmaceutical.
Currently, the analyst consensus on BioNTech SE is a Moderate Buy with an average price target of $286.00.
BioNTech SE’s market cap is currently $40.02B and has a P/E ratio of 4.47.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
BioNTech SE is a Germany-based biotechnology company that develops and manufactures immunotherapies for cancer, infectious diseases, allergies and autoimmune disorders.
Read More on BNTX: